Health insurance benefit limits: General concepts and the potential impact on dermatologic treatment - 21/08/11
Doi : 10.1016/j.jaad.2004.11.032
Arun P. Venkat, MD, MBA a, Noah S. Scheinfeld, MD, JD b, Amit S. Kulkarni, MS c, Rajesh Balkrishnan, PhD c, Steven R. Feldman, MD, PhD a, ⁎ 
a From the Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem
b Columbia University Department of Dermatology, St Lukes-Roosevelt Hospital Center, New York
c School of Public Health, University of Texas Health Sciences Center
Correspondence to: Steven R. Feldman, MD, PhD, Department of Dermatology, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157.Winston-Salem, North Carolina; New York, New York; and Houston, Texas
| The Center for Dermatology Research is funded by a grant from Galderma. Disclosure: Dr Feldman has received consulting/speaking/research support from Genentech, Biogen, Amgen, and Centorcor. Reprints not available from the authors. |
© 2005
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 53 - N° 1
P. 140-142 - juillet 2005 Retour au numéro
Article précédent
- Bound volumes available to subscribers
- Surgical Pearl: Artificial skin model for simulation of flap mechanics
- Carlos Garcia, Raashid Haque, Eduardo Poletti
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?